Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Science 24 September 1982:
Vol. 217. no. 4566, pp. 1263 - 1265
DOI: 10.1126/science.7112129

Articles

Science, Vol 217, Issue 4566, 1263-1265
Copyright © 1982 by American Association for the Advancement of Science


articles

Cystine transport is defective in isolated leukocyte lysosomes from patients with cystinosis

WA Gahl, N Bashan, F Tietze, I Bernardini, and JD Schulman

The activity of a cystine transport system in lysosomes prepared from the leukocytes of patients with cystinosis was found to be deficient. In normal subjects, this system was resistant to N-ethylmaleimide and demonstrated saturation kinetics. Lysosomes from individuals heterozygous for cystinosis demonstrated a reduced maximum velocity for cystine egress from lysosomes. The rate of cystine escape from normal lysosomes was enhanced by adenosine triphosphate. The availability of normal and mutant lysosomes provides a means of investigating mechanisms of amino acid transport across lysosomal membranes.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Nephropathic Cystinosis in Adults: Natural History and Effects of Oral Cysteamine Therapy.
W. A. Gahl, J. Z. Balog, and R. Kleta (2007)
Ann Intern Med 147, 242-250
   Abstract »    Full Text »    PDF »
Coronary Artery and Other Vascular Calcifications in Patients with Cystinosis after Kidney Transplantation.
M. Ueda, K. O'Brien, D. R. Rosing, A. Ling, R. Kleta, D. McAreavey, I. Bernardini, and W. A. Gahl (2006)
Clin. J. Am. Soc. Nephrol. 1, 555-562
   Abstract »    Full Text »    PDF »
Molecular pathogenesis of cystinosis: effect of CTNS mutations on the transport activity and subcellular localization of cystinosin.
V. Kalatzis, N. Nevo, S. Cherqui, B. Gasnier, and C. Antignac (2004)
Hum. Mol. Genet. 13, 1361-1371
   Abstract »    Full Text »    PDF »
Renal Epithelial Traffic Jams and One-Way Streets.
M. A.J. Devonald and F. E. Karet (2004)
J. Am. Soc. Nephrol. 15, 1370-1381
   Full Text »    PDF »
The H+-Coupled Electrogenic Lysosomal Amino Acid Transporter LYAAT1 Localizes to the Axon and Plasma Membrane of Hippocampal Neurons.
C. C. Wreden, J. Johnson, C. Tran, R. P. Seal, D. R. Copenhagen, R. J. Reimer, and R. H. Edwards (2003)
J. Neurosci. 23, 1265-1275
   Abstract »    Full Text »    PDF »
A multicentre randomised double masked clinical trial of a new formulation of topical cysteamine for the treatment of corneal cystine crystals in cystinosis.
E T Tsilou, D Thompson, A S Lindblad, G F Reed, B Rubin, W Gahl, J Thoene, M Del Monte, J A Schneider, D B Granet, et al. (2003)
Br J Ophthalmol 87, 28-31
   Abstract »    Full Text »    PDF »
Intralysosomal Cystine Accumulation in Mice Lacking Cystinosin, the Protein Defective in Cystinosis.
S. Cherqui, C. Sevin, G. Hamard, V. Kalatzis, M. Sich, M. O. Pequignot, K. Gogat, M. Abitbol, M. Broyer, M.-C. Gubler, et al. (2002)
Mol. Cell. Biol. 22, 7622-7632
   Abstract »    Full Text »    PDF »
Cystinosis: from gene to disease.
V. Kalatzis and C. Antignac (2002)
Nephrol. Dial. Transplant. 17, 1883-1886
   Full Text »    PDF »
Immunolocalization of Cystinosin, the Protein Defective in Cystinosis.
M. R. Haq, V. Kalatzis, M.-C. Gubler, M. M. Town, C. Antignac, W. G. van't Hoff, and A. S. Woolf (2002)
J. Am. Soc. Nephrol. 13, 2046-2051
   Abstract »    Full Text »    PDF »
Inhibition of Na+-Dependent Transporters in Cystine-Loaded Human Renal Cells: Electrophysiological Studies on the Fanconi Syndrome of Cystinosis.
I. CCetinkaya, E. Schlatter, J. R. Hirsch, P. Herter, E. Harms, and R. Kleta (2002)
J. Am. Soc. Nephrol. 13, 2085-2093
   Abstract »    Full Text »    PDF »
Cystinosis: Antibodies and Healthy Bodies.
R. Kleta and W. A. Gahl (2002)
J. Am. Soc. Nephrol. 13, 2189-2191
   Full Text »    PDF »
Cystinosis.
W. A. Gahl, J. G. Thoene, and J. A. Schneider (2002)
N. Engl. J. Med. 347, 111-121
   Full Text »    PDF »
Pulmonary Dysfunction in Adults With Nephropathic Cystinosis.
Y. Anikster, F. Lacbawan, M. Brantly, B. L. Gochuico, N. A. Avila, W. Travis, and W. A. Gahl (2001)
Chest 119, 394-401
   Abstract »    Full Text »    PDF »
The Genomic Region Encompassing the Nephropathic Cystinosis Gene (CTNS): Complete Sequencing of a 200-kb Segment and Discovery of a Novel Gene within the Common Cystinosis-Causing Deletion.
J. W. Touchman, Y. Anikster, N. L. Dietrich, V. V. B. Maduro, G. McDowell, V. Shotelersuk, G. G. Bouffard, S. M. Beckstrom-Sternberg, W. A. Gahl, and E. D. Green (2000)
Genome Res. 10, 165-173
   Abstract »    Full Text »
Fully automated assay for total homocysteine, cysteine, cysteinylglycine, glutathione, cysteamine, and 2-mercaptopropionylglycine in plasma and urine.
A. Pastore, R. Massoud, C. Motti, A. L. Russo, G. Fucci, C. Cortese, and G. Federici (1998)
Clin. Chem. 44, 825-832
   Abstract »    Full Text »    PDF »
Consultation with the Specialist: Nephropathic Cystinosis.
W. A. Gahl (1997)
Pediatr. Rev. 18, 302-304
   Full Text »    PDF »
Detection and Characterization of a Transport System Mediating Cysteamine Entry into Human Fibroblast Lysosomes.
R. L. Pisoni, G. Y. Park, V. Q. Velilla, and J. G. Thoene (1995)
J. Biol. Chem. 270, 1179-1184
   Abstract »    Full Text »    PDF »
Classic Nephropathic Cystinosis as an Adult Disease.
D. S. Theodoropoulos, D. Krasnewich, M. I. Kaiser-Kupfer, and W. A. Gahl (1993)
JAMA 270, 2200-2204
   Abstract »    PDF »
Improved Renal Function in Children with Cystinosis Treated with Cysteamine.
T. C. Markello, I. M. Bernardini, and W. A. Gahl (1993)
N. Engl. J. Med. 328, 1157-1162
   Abstract »    Full Text »
A Randomized Placebo-Controlled Trial of Cysteamine Eye Drops in Nephropathic Cystinosis.
M. I. Kaiser-Kupfer, M. A. Gazzo, M. B. Datiles, R. C. Caruso, E. M. Kuehl, and W. A. Gahl (1990)
Arch Ophthalmol 108, 689-693
   Abstract »    PDF »
Neurologic Complications in Long-standing Nephropathic Cystinosis.
J. K. Fink, P. Brouwers, N. Barton, H. M. Mohammed, S. Sato, S. Hill, W. E. Cohen, B. Fivush, and W. A. Gahl (1989)
Arch Neurol 46, 543-548
   Abstract »    PDF »
Cystinosis: Progress in a Prototypic Disease.
W. A. Gahl, J. G. Thoene, J. A. Schneider, S. O'Regan, M. I. Kaiser-Kupfer, and T. Kuwabara (1988)
Ann Intern Med 109, 557-569
   Abstract »    PDF »
Pancreatic Endocrine Insufficiency in Posttransplant Cystinosis.
B. Fivush, O. C. Green, C. C. Porter, J. W. Balfe, S. O'Regan, and W. A. Gahl (1987)
Arch Pediatr Adolesc Med 141, 1087-1089
   Abstract »    PDF »
Defective sialic acid egress from isolated fibroblast lysosomes of patients with Salla disease.
M Renlund, F Tietze, and W. Gahl (1986)
Science 232, 759-762
   Abstract »    PDF »
Long-term Ocular Manifestations in Nephropathic Cystinosis.
M. I. Kaiser-Kupfer, R. C. Caruso, D. S. Minkler, and W. A. Gahl (1986)
Arch Ophthalmol 104, 706-711
   Abstract »    PDF »
Defect in vitamin B12 release from lysosomes: newly described inborn error of vitamin B12 metabolism.
D. Rosenblatt, A Hosack, N. Matiaszuk, B. Cooper, and R Laframboise (1985)
Science 228, 1319-1321
   Abstract »    PDF »
The Targeting of Cystinosin to the Lysosomal Membrane Requires a Tyrosine-based Signal and a Novel Sorting Motif.
S. Cherqui, V. Kalatzis, G. Trugnan, and C. Antignac (2001)
J. Biol. Chem. 276, 13314-13321
   Abstract »    Full Text »    PDF »



To Advertise     Find Products


Science. ISSN 0036-8075 (print), 1095-9203 (online)